Geode Capital Management, LLC Cidara Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

  • $1.07 Trillion
  • Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Cidara Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 838,286 shares of CDTX stock, worth $9.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
838,286
Previous 805,871 4.02%
Holding current value
$9.4 Million
Previous $636,000 21.23%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$0.64 - $0.92 $20,745 - $29,821
32,415 Added 4.02%
838,286 $771,000
Q3 2023

Nov 13, 2023
BUY
$0.77 - $1.16 $60,183 - $90,666
78,161 Added 10.74%
805,871 $757,000
Q2 2023

Aug 11, 2023
BUY
$1.01 - $1.42 $68,723 - $96,621
68,043 Added 10.31%
727,710 $822,000
Q1 2023

May 15, 2023
BUY
$0.75 - $1.98 $50,207 - $132,547
66,943 Added 11.29%
659,667 $837,000
Q4 2022

Feb 13, 2023
BUY
$0.48 - $0.76 $3,716 - $5,884
7,743 Added 1.32%
592,724 $448,000
Q3 2022

Nov 14, 2022
BUY
$0.45 - $0.81 $37,319 - $67,174
82,932 Added 16.52%
584,981 $367,000
Q2 2022

Aug 12, 2022
BUY
$0.43 - $0.91 $11,168 - $23,635
25,973 Added 5.46%
502,049 $245,000
Q1 2022

May 13, 2022
BUY
$0.67 - $1.39 $63,286 - $131,296
94,458 Added 24.75%
476,076 $396,000
Q3 2021

Nov 12, 2021
BUY
$1.48 - $2.35 $25,834 - $41,021
17,456 Added 4.79%
381,618 $854,000
Q2 2021

Aug 13, 2021
SELL
$1.87 - $2.7 $423,005 - $610,756
-226,206 Reduced 38.32%
364,162 $735,000
Q1 2021

May 12, 2021
BUY
$2.06 - $3.01 $277,341 - $405,242
134,632 Added 29.54%
590,368 $1.57 Million
Q4 2020

Feb 12, 2021
BUY
$1.99 - $3.25 $15,231 - $24,875
7,654 Added 1.71%
455,736 $911,000
Q3 2020

Nov 13, 2020
BUY
$2.85 - $4.1 $26,584 - $38,244
9,328 Added 2.13%
448,082 $1.28 Million
Q2 2020

Aug 13, 2020
BUY
$2.39 - $4.0 $522,800 - $874,980
218,745 Added 99.43%
438,754 $1.62 Million
Q1 2020

May 14, 2020
BUY
$1.74 - $4.26 $177,951 - $435,674
102,271 Added 86.86%
220,009 $545,000
Q4 2019

Feb 13, 2020
BUY
$1.77 - $3.84 $3,090 - $6,704
1,746 Added 1.51%
117,738 $452,000
Q3 2019

Nov 12, 2019
BUY
$1.25 - $2.35 $61,271 - $115,189
49,017 Added 73.19%
115,992 $231,000
Q2 2019

Aug 14, 2019
BUY
$1.49 - $2.94 $6,995 - $13,803
4,695 Added 7.54%
66,975 $112,000
Q2 2018

Aug 14, 2018
BUY
$3.75 - $6.05 $69,708 - $112,463
18,589 Added 42.55%
62,280 $323,000
Q4 2017

Feb 13, 2018
SELL
$6.35 - $8.75 $27,311 - $37,633
-4,301 Reduced 8.96%
43,691 $297,000
Q2 2017

Aug 14, 2017
BUY
N/A
47,992
47,992 $359,000

Others Institutions Holding CDTX

# of Institutions
53
Shares Held
22.2M
Call Options Held
2.7K
Put Options Held
100
View Full List

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $786M
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email